SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending amid community speculation about a confirmed COEP merger and its potential integration into Elon Musk's X platform, fueling a sharp divide between those anticipating massive gains and others warning of an inevitable pump-and-dump cycle.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is gaining strong community attention and bullish sentiment, driven by reports of increased institutional holdings through ETFs and discussions around its potential decoupling from Bitcoin, all while participants eagerly await clarity from the anticipated Digital Asset Market Clarity Act.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is trending amidst buzz about its maxed-out token supply and potential for a "supply shock," as the community eagerly anticipates upcoming V4 developments and new fintech partnerships to drive a significant breakout.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens is trending as the community discusses its 'Dawn of Utility' following the X-Ray privacy protocol upgrade and reports of CME Group planning futures, with many highlighting its growing real-world asset tokenization and institutional partnerships amidst recent price fluctuations.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE CRYPTO is trending amidst strong upward momentum, fueled by community discussions anticipating a potential "altcoin" or "meme season" rally, with its price action closely tracking broader crypto market sentiment. The community is sharply divided, with many eyeing significant gains and a "next leg up," while others express caution, foresee a sharp correction, or label it a "scam."

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending amid a perceived 'meme coin season' and a broader crypto market rally, sparking community excitement about a potential rebound. Discussion highlights significant whale accumulation and technical indicators suggesting a bullish reversal, with many calling for continued upward momentum while some express skepticism.

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments. The Biotechnology segment is involved in developing biotechnology product pipelines. The Technology segment relates to acquiring technology assets to support and enhance operational capabilities through advanced technologies. The company was founded in 2017 and is headquartered in Wexford, PA.

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Inc

Coeptis Therapeutics is drawing significant attention following shareholder approval of its transformative merger with Z Squared, a prominent Dogecoin mining operation, shifting its core business from biotech to a crypto-centric model. The community is actively discussing the potential for a substantial short squeeze and price surge as the merger approaches finalization, with many eyeing its correlation to Dogecoin's performance amidst prevailing market sentiment.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending amidst discussions of its real-world utility, with FedEx joining its Governing Council and reports of the U.S. Military adopting its quantum-resistant technology for secure drones. While many in the community highlight its enterprise partnerships and leadership in Real-World Asset development as key long-term catalysts, others express frustration with its price performance.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin ($XCN) is trending amidst high anticipation for its Project Goliath mainnet, Chain 2.0's rollout of enterprise stablecoin infrastructure with direct banking rails, and the potential boost from the proposed Clarity Act, with the community actively debating significant whale accumulation and underlying market dynamics.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is drawing significant attention with upcoming presentations at the Glioblastoma Drug Development Summit and highly anticipated updated lung cancer data, fueling community speculation about potential acquisitions or partnerships from Big Pharma seeking to bolster pipelines amid significant patent expirations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM CONTACT: INVESTOR ALERT...

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to...

<ul class="summary-bullets"><li>The stock surged as Canadian media spotlight renewed scrutiny of Quantum’s alleged market-spoofing case.</li><li>The coverage drew fresh attention to the company’s $700 million federal lawsuit over price manipulation.</li><li>Lucid-MS’s Phase 1 safety data in August supported advancement toward patient trials.</li></ul>Quantum BioPharma shares surged on Tuesday after a Canadian media investigation spotlighted the company’s claims that years of alleged stock spoofing depressed its valuation and harmed its lead multiple-sclerosis program. The renewed attention came as CTV’s investigative flagship W5 began airing a three-part series examining Quantum’s lawsuit seeking more than $700 million in damages.The stock closed up 30% at $8.04 on Tuesday and added another 5% in after-hours trading.<h2 class="st-heading-2">CTV Investigation Highlights Company’s Manipulation Claims</h2>The W5 series focuses on Quantum’s allegation that its shares were repeatedly manipulated through illegal “stock spoofing” conducted by CIBC World Markets, RBC Dominion Securities and others from January 2020 to August 2024. The practice, which involves placing and canceling non-bona fide buy and sell orders, is prohibited in both Canada and the U.S.W5 reporter Jon Woodward previewed the first installment in an article titled “Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?” The program began airing Part One on Tuesday, drawing renewed attention to Quantum’s claims and its ongoing legal fight.<h2 class="st-heading-2">Quantum Alleges Banks Used Spoofing To Drive Shares Lower</h2>Quantum filed its initial complaint in October 2024 in the U.S. District Court for the Southern District of New York and amended it in May after defendants moved to dismiss. The company alleges violations of the Securities Exchange Act, asserting that hundreds of spoofing events artificially pushed its stock lower.Quantum said its shares traded above $460 on a split-adjusted basis in early 2020 with a market cap near $1 billion, compared with $7.55 by October 2024. The firm also maintains that additional banks or brokers may have been involved, but said it will not identify them until it has gathered sufficient evidence.The law firms Christian Attar and Freedman Normand Friedland LLP are pursuing the case on a contingency basis after conducting an extensive investigation with industry experts.<h2 class="st-heading-2">Progress In Lucid-MS Program&nbsp;</h2>In August, Quantum BioPharma reported that its lead multiple sclerosis candidate, Lucid-MS, passed a key safety hurdle after a Phase 1 multiple-ascending-dose study found no safety or tolerability issues in healthy volunteers. The company said the clinical study report supported its plans to advance into patient efficacy trials.Lucid-MS is a first-in-class, non-immunomodulatory neuroprotective compound designed to prevent or reverse myelin degradation, based on preclinical data.&nbsp;<h2 class="st-heading-2">Stocktwits Users Eye A Sharp Rebound</h2>On Stocktwits, retail sentiment for Quantum BioPharma was ‘extremely bullish’ amid a 3,400% surge in 24-hour message volume.<figure class="image"><img style="aspect-ratio:971/141;" src="https://news.stocktwits-cdn.com/qntm_ss_png_e73bb7bac7.webp" alt="qntm ss.png" width="971" height="141"><figcaption>QNTM sentiment and message volume as of November 26 | Source: Stocktwits</figcaption></figure>One user predicted, “shorts will be covering tomorrow due to thanksgiving. Should see $18 soon.”<stembedurl>https://stocktwits.com/James9921/message/637453956</stembedurl>Another user said, “this one has been absolutely wrecked here but historically when the stocks this low it sees a violent move up. Watching closely here.”<stembedurl>https://stocktwits.com/makedatbread88/message/637220177</stembedurl><a href="https://stocktwits.com/symbol/QNTM">Quantum BioPharma’s stock</a> has more than doubled so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Quantum BioPharma’s stock (QNTM) has more than doubled so far in 2025. (Photo credit: Getty Images)

Quantum BioPharma Stock Rockets As Media Probe Shines Light On Spoofing Allegations Linked To Its $700M Lawsuit

Lucid-MS’s Phase 1 safety data in August supported advancement toward patient trials.

Equity

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights QNTM

The DJS Law Group announces that it is investigating claims on behalf of investors of Quantum BioPharma Ltd. (Quantum BioPharma or the Company) (NASDAQ: QNTM) for violations of the securities laws...

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quantum BioPharma Ltd. (Quantum BioPharma or the Company...

Quantum BioPharma (QNTM) on Monday announced that it has signed an agreement with a leading contract development and manufacturing organization to manufacture an oral drug formulation of Lucid-MS.The agreement was signed through Quantum’s subsidiary, Huge Biopharma Australia Pty. Quantum, however, did not name the contract manufacturer.The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/08/11/3130819/0/en/Quantum-BioPharma-Signs-Agreement-to-Manufacture-Oral-Drug-Formulation-of-its-Potential-Breakthrough-Drug-Lucid-21-302-Lucid-MS-for-Use-in-its-Upcoming-Phase-2-Multiple-Sclerosis-T.html">intends</a> to study the oral formulation of Lucid-MS in a mid-stage clinical trial and test its efficacy on humans as a possible treatment for people to regain mobility lost with multiple sclerosis (MS).Multiple Sclerosis is a chronic, often disabling, autoimmune disease that disrupts communication between the brain and other parts of the body. The symptoms include difficulty in walking, blurred vision, and altered sensations in limbs or face. In MS, the body's immune system mistakenly attacks healthy tissue, damaging the myelin sheath or the protective covering of nerve fibers.Lucid-MS is a patented chemical entity shown to prevent and reverse myelin degradation in preclinical models. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/QNTM">QNTM</a> fell from ‘extremely bullish’ to ‘bullish’ territory over the past 24 hours, while message volume fell from ‘extremely high’ to ‘high’ levels. Shares of the company rose 4% in the pre-market session at the time of writing.Quantum said that numerous animal models over the past decade showed Lucid-MS helped those animals regain their ability to walk. “We are pleased to announce that we have signed this agreement with a leading CDMO to develop and manufacture an oral formulation of Lucid-MS. This marks an important step in the clinical development of Lucid-MS as we prepare the Investigational New Drug (IND) application with the FDA and prepare for our upcoming Phase 2 trial of Lucid-21-302 in MS,” said Andrzej Chruscinski, Vice-President, Scientific and Clinical Affairs at Quantum Biopharma.QNTM stock is up by 694% this year and by about 246% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/paramount-acquires-ufc-rights-for-7-7-billion-7-years-skydance-merger/chruxI6RdIu">Paramount Acquires UFC Rights For $7.7 Billion In A 7-Year Deal, Days After Skydance Merger</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Why Is Quantum BioPharma In The News Today? Here’s An Important Update On Its Multiple Sclerosis Investigational Drug

The company intends to study the oral formulation of Lucid-MS in a mid-stage clinical trial and test its efficacy on humans as a possible treatment for people to regain mobility lost with multiple sclerosis (MS).

Quantum BioPharma drew increased retail buzz on Monday following its announcement of a new $1 million Bitcoin and cryptocurrency investment, which increased its crypto holdings to $4.5 million.The company’s shares climbed 19.61% to close at $12.26 on Monday before easing 2.85% to $11.91 in after-hours trading.The board-sanctioned investment supports the company’s established strategy of employing digital assets to protect against currency fluctuations while generating potential shareholder value.&nbsp;Quantum BioPharma confirmed that all digital assets are secured by a certified custodian and that future funding activities could use cryptocurrency.The company plans to modify its portfolio holdings according to current market trends.Quantum owns 20.11% of Celly Nutrition Corp., which sells the over-the-counter Unbuzzd product and pays Quantum royalties up to $250 million before starting perpetual 3% royalties.Meanwhile, its unit, Lucid Psycheceuticals, works on the preclinical multiple sclerosis therapy, Lucid-MS.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 4,200% increase in 24-hour message volume.One user noted that the stock remains under the radar, suggesting&nbsp;it is still in its early stages despite growing interest.&nbsp;<stembedurl>https://stocktwits.com/Bull93/message/615150520</stembedurl>Another pointed out that the stock has posted gains while maintaining relatively low trading volume, describing the move as “steady.”<stembedurl>https://stocktwits.com/Kerrz/message/615138127</stembedurl>The stock has surged over 200% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Portrait of a doctor woman on the background of stock charts. | Image source: Getty Images

Quantum BioPharma Stock Pops 20%, Retail Bullish Sentiment Builds After $1M Crypto Holdings Boost

The company increased its Bitcoin and cryptocurrency holdings to $4.5 million, reinforcing its strategy to hedge against currency fluctuations and improve shareholder value. 

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$3.64
Prev Close	$3.65
Open	$3.66
Dividend Yield	0.00%
50-Day Moving Average	$7.03
Beta	1.36
Avg. Volume	61,817.85
PE Ratio	-0.35

52-Week High	$38.25
52-Week Low	$3.62
Market Capitalization	$13.99M
EPS (Annual)	-$12.49
Price to Book	1.61
Revenue Per Employee	$0.00

QNTM
Quantum BioPharma Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest QNTM News

QNTMQuantum BioPharma Ltd